Anthony D. Villella

Hematology | Oncology

700 Childrens Dr
Columbus, OH 43205

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.

Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.

Journal: JAMA

Published: August 19, 2026

When Cure Meets Susceptibility: APOL1-Associated Kidney Injury After Gene Therapy for Sickle Cell Disease.

When Cure Meets Susceptibility: APOL1-Associated Kidney Injury After Gene Therapy for Sickle Cell Disease.

Journal: American journal of hematology

Published: April 14, 2026

When Cure Meets Susceptibility: APOL1-Associated Kidney Injury After Gene Therapy for Sickle Cell Disease.

When Cure Meets Susceptibility: APOL1-Associated Kidney Injury After Gene Therapy for Sickle Cell Disease.

Journal: American journal of hematology

Published: April 14, 2026

National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance: A Consensus Statement.

National Alliance of Sickle Cell Centers Consensus Recommendations on Sickle Cell Disease Health Maintenance: A Consensus Statement.

Journal: JAMA network open

Published: November 13, 2025

Safety and efficacy of anti-coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience.

Safety and efficacy of anti-coagulation for primary and secondary venous thromboembolism prophylaxis in hospitalized adolescents and young adults with sickle cell disease: An institutional experience.

Journal: British journal of haematology

Published: October 11, 2025

Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain.

Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain.

Journal: JAMA pediatrics

Published: September 02, 2025

Hospital Variations in Time-To-Crisis-Resolution Among Children and Adolescents With Sickle Cell Disease.

Hospital Variations in Time-To-Crisis-Resolution Among Children and Adolescents With Sickle Cell Disease.

Journal: American journal of hematology

Published: August 07, 2025

Clinical Trials or FDA-Approved Therapies? The Ethics of Sickle Cell Gene Therapy Access.

Clinical Trials or FDA-Approved Therapies? The Ethics of Sickle Cell Gene Therapy Access.

Journal: The American journal of bioethics : AJOB

Published: April 07, 2025

Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease.

Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease.

Journal: Pediatric blood & cancer

Published: February 20, 2025

Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype.

Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype.

Journal: Pediatric blood & cancer

Published: January 08, 2025

Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future.

Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future.

Journal: Current neurology and neuroscience reports

Published: August 14, 2024

Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States.

Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States.

Journal: Pediatric blood & cancer

Published: December 19, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026